Skip to main content
Livermore
Livermore
ZHEN

Morgan Stanley

SEC CIK
0000895421
Latest filing
Aug 13, 2026

NNVC holding history

Nanoviricides, Inc. in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NNVC overviewAll 13F holders of NNVCFull Q2 2026 holdings

Shares (Q2 2026)
2,616
Value
$3.61K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of NNVC by Morgan Stanley, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,616$3.61K<0.1%00.0%UnchangedHolders
Q1 20262,616$2.39K<0.1%−16,035−86.0%ReducedHolders
Q4 202518,651$21.1K<0.1%+16,704+857.9%AddedHolders
Q3 20251,947$2.78K<0.1%00.0%UnchangedHolders
Q2 20251,947$2.73K<0.1%+1,831+1,578.4%AddedHolders
Q1 2025116$136<0.1%00.0%UnchangedHolders
Q4 2024116$166<0.1%−145−55.6%ReducedHolders
Q3 2024261$392<0.1%−1,000−79.3%ReducedHolders
Q2 20241,261$2.17K<0.1%+1,024+432.1%AddedHolders
Q1 2024237$275<0.1%00.0%UnchangedHolders
Q4 2023237$242<0.1%00.0%UnchangedHolders
Q3 2023237$318<0.1%00.0%UnchangedHolders
Q2 2023237$273<0.1%+150+172.4%AddedHolders
Q1 202387$102<0.1%00.0%UnchangedHolders
Q4 202287$97<0.1%−23,682−99.6%ReducedHolders
Q3 202223,769$41.0K<0.1%+23,646+19,224.4%AddedHolders
Q2 2022123$00.0%−637−83.8%ReducedHolders
Q1 2022760$2.00K<0.1%−543−41.7%ReducedHolders
Q4 20211,303$5.00K<0.1%−2,150−62.3%ReducedHolders
Q3 20213,453$16.0K<0.1%+10.0%AddedHolders
Q2 20213,452$16.0K<0.1%00.0%UnchangedHolders
Q1 20213,452$16.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.